RNA therapeutics is at a critical stage following the success of the COVID-19 mRNA vaccines. Beyond mRNA vaccines, innovative developments are being made using siRNA, microRNA, tRNA and circular RNA technologies.
RNA Therapeutic Modalities Summit is taking place in Boston from 15-16 June 2022 to highlight the latest innovations in the RNA field. View the full conference schedule here.
BioNTech, Amgen, Tevard Biosciences, Dyne Therapeutics, Replicate Bioscience, Anima Biotech, Regulus Therapeutics, Interna Sirnaomics are amongst those attending North Americas’ only industry-led conference that covers clinical progress and commercial-scale development across the full spectrum of RNA therapeutic approaches.
Meet with 25+ RNA experts including:
- Raymond Deshaies, SVP Global Research, Amgen
- Karin Jooss, EVP, Head of R&D, Gritstone Bio
- Stephanie Erbar, Head of Infectious Disease Vaccines, BioNTech
- Armon Sharei, CEO, SQZ Biotech
The Summit will be advantageous to the RNA field, aiding:
- Improvement of stability, delivery, and durability of RNA-based therapeutics
- Optimizing power and versatility of RNA-based constructs, while improving tissue-specific delivery and reducing toxicity
- Applying therapeutics for disease indications across neurodegenerative disease, rare disease and oncology
Secure your place now – early bird ends March 11 – save up to $1000! Contact events@kisacoresearch.com for more information about group booking discounts.